Albunorm

Composition: Albumin

Form: Infusion solution

Indications: Hypoalbuminemia, shock, nephrotic syndrome, severe burns, ascites, acute liver injury, cerebral edema, ARDS, hemolytic disease of the newborn, therapy during plasmapheresis and hemodialysis.

Contraindications: Hypersensitivity to albumin, severe anemia, hypervolemia, pulmonary edema, thrombosis, active internal bleeding, arterial hypertension, chronic heart failure (stage II–III).

Dosage: Intravenously via drip or bolus. Adults: up to 100 ml of 20% solution at a time. Children: 1–3 ml/kg. Administration rate — no more than 1–2 ml/min. Administered only in hospital settings.

Side effects: Rare: anaphylaxis, hypotension. Very rare: urticaria, tachycardia, dyspnea, fever, confusion, rash.

Interactions: No specific drug interactions described. Do not mix with other medications, whole blood, protein hydrolysates, amino acids, or alcohol-containing solutions.

Warnings: Do not use if solution is cloudy or vial integrity is compromised. Monitor electrolyte and fluid balance. Reactions may occur in sensitized patients.

Age restrictions: For adults and children as indicated

Pregnancy: Safety not established, but no harmful effects on fetus or newborn expected. Use if necessary.

Country of origin: Austria

Manufacturer: Octapharma Pharmazeutika Produktionsges.m.b.H

Storage conditions: Store at 2°C to 25°C in a light-protected place. Do not freeze.